Table 3.
Histologic diagnoses and DSA status in the Kidney 300 cohort (n, % of total)
| Molecular Diagnoses | Histology Diagnoses | |||
|---|---|---|---|---|
| n (% of 300) | % DSA Positive of Those Tested | n (% of 300) | % DSA Positive of Those Tested | |
| No rejection | 175 (58)a | 6 | 128 (43)a | 9 |
| Possible TCMR (pTCMR) | 6 (2) | 0 | 31 (10) | 10 |
| TCMR | 21 (7)a | 29 | 31 (10)a | 19 |
| Possible ABMR (pABMR) | 12 (4) | 50 | 35 (12) | 26 |
| ABMR | 67 (22)a | 33 | 45 (15)a | 44 |
| Mixed (ABMR+TCMR) | 19 (6)a | 50 | 15 (5)a | 40 |
| All ABMR (including Mixed) | 86 (29) | 36 | 60 (20) | 37 |
| Inadequate | — | — | 6 (2) | — |
| Missing | — | — | 9 (3) | — |
| Automated rejection archetypes | ||||
|---|---|---|---|---|
| n (% of 300) | % DSA positive of those tested | |||
| No rejection | 180 (60)a | 20 | ||
| TCMR1 (many mixed) | 9 (3)a | 50 | ||
| TCMR2 | 22 (7) | 29 | ||
| EABMR | 31 (10)a | 44 | ||
| FABMR | 40 (13)a | 58 | ||
| LABMR | 18 (6) | 38 | ||
LABMR, late-stage ABMR.
a
Groups with specific references in text.